Quantitative assessment of retroviral transfer of the human multidrug resistance 1 gene to human mobilized peripheral blood progenitor cells engrafted in nonobese diabetic/severe combined immunodeficient mice

Blood

Volumn 95, Issue 4, 2000, Pages 1237-1248

  Schiedlmeier, B ^b   Kuhlcke K ^b   Eckert, H G ^b   Baum, C ^b   Zeller, W J ^b   Fruehauf, Stefan ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FLT3 LIGAND; GLYCOPROTEIN P; INTERLEUKIN 3; INTERLEUKIN 6; RHODAMINE 123; STEM CELL FACTOR; THROMBOPOIETIN; VASCULOTROPIN; VIRUS VECTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE TRANSFER; GENETIC TRANSDUCTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; RETROVIRUS; TRANSGENE;

EID: 0342470476     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v95.4.1237     Document Type: Article

References (90)

1. To LB, Haylock DN, Simmons PJ, Juttner CA. The biology and clinical uses of blood stem cells. Blood. 1997;89:2233.
2. Savarese DM, Hsieh C, Stewart FM. Clinical impact of chemotherapy dose escalation in patients with hematological malignancies and solid tumors. J Clin Oncol. 1997;15:2981.
3. Sorrentino BP, Brandt SJ, Gottesman M, Pastan I, Cline A, Nienhuis AW. Selection of drug-resistant bone marrow cells in vivo after retroviral transfer of the human MDR1. Science. 1992; 257:99.
4. Flasshove M, Banerjee D, Mineishi S, Li MX, Bertino JR, Moore MAS. Ex vivo expansion and selection of human CD34+ peripheral blood progenitor cells after introduction of a mutated dihydrofolatereductase cDNA via retroviral gene transfer. Blood. 1995;85:566.
5. 6-benzylguanine plus 1,3-bis(2-chloroethyl)-1-nitrosourea. Proc Natl Acad Sci U S A. 1996;93:14,088.
6. Chaudhary PM, Roninson IB. Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells. Cell. 1991; 66:85.
7. Gottesman MM, Pastan I. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem. 1993;62:385.
8. Boesen JJB, Nooter K, Valerio D. Circumvention of chemotherapy-induced myelosuppression by transfer of the mdr1 gene. Biotherapy. 1994;6: 291.
9. Mickisch GH, Aksentijevich I, Schoenlein PV, et al. Transplantation of bone marrow cells from transgenic mice expressing the human MDR1 gene results in long-term protection against the myelosuppressive effect of chemotherapy in mice. Blood. 1992;79:1087.
10. Hanania EG, Fu S, Roninson I, Zu Z, Gottesman MM, Deisseroth AB. Resistance to Taxol chemotherapy produced in mouse marrow cells by safety-modified retroviruses containing a human MDR-1 transcription unit. Gene Ther. 1995;2:279.
11. Kiem HP, Darovsky B, von Kalle C, et al. Long-term persistence of canine hematopoietic cells genetically marked by retrovirus vectors. Hum Gen Ther. 1995;7:89.
12. Kiem HP, Heyward S, Winkler A, et al. Comparison between amphotropic and gibbon ape leukemia virus pseudotyped retroviral vectors in a competitive repopulation assay in baboons. Blood. 1997;90:4638.
13. Van Beusechem VW, Valerio D. Gene transfer into hematopoietic stem cells of nonhuman primates. Hum Gene Ther. 1996;7:1649.
14. Hesdorffer C, Ayello J, Ward M, et al. Phase I clinical trial of retroviral-mediated transfer of the human MDR1 gene as marrow chemoprotection in patients undergoing high-dose chemotherapy and autologous stem-cell transplantation. J Clin Oncol. 1998;16:165.
15. Deisseroth AB, Zu Z, Claxton D, et al. Genetic marking shows that Ph+ cells present in autologous transplants of chronic myelogenous leukemia (CML) contribute to relapse after autologous bone marrow transplantation in CML. Blood. 1994;83:3068.
16. Dunbar C, Cottler-Fox M, O'Shaughnessey JA, et al. Retrovirally marked CD34-enriched peripheral blood and bone marrow cells contribute to long-term engrattment after autologous transplantation. Blood. 1995;85:3048.
17. Emmons RVB, Doren S, Zujewski J, et al. Retroviral gene transduction of adult peripheral blood or marrow-derived CD34+ cells for six hours without growth factors or on autologous stroma does not improve marking efficiency assessed in vivo. Blood. 1997;89:4040.
18. Miller DG, Adam MA, Miller AD. Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection. Mol Cell Biol. 1990;10:4239.
19. Lewis PF, Emerman M. Passage through mitosis is required for oncoretroviruses but not for human immunodeficiency virus. J Virol. 1994;68:510.
20. Challita P-M, Kohn DB. Lack of expression from a retroviral vector after transduction of murine hematopoietic stem cells is associated with methylation in vivo. Proc Natl Acad Sci U S A. 1994;91: 2567.
21. Lu M, Zhang N, Maruyama M, Hawley RG, Ho AD. Retrovirus-mediated gene expression in hematopoietic cells correlates inversely with growth factor stimulation. Hum Gene Ther. 1996;7:2263.
22. Greiner DL, Hesselton RA, Shultz LD. SCID mouse models of human stem cell engraftment. Stem Cells. 1998;16:166.
23. Kamel-Reid S, Dick J. Engraftment of immunodeficient mice with human hematopoietic stem cells. Science. 1988;242:1706.
24. Lapidot T, Pflumio F, Doedens CE, Murdoch B, Williams DE, Dick JE. Cytokine stimulation of multilineage hematopoiesis from immature human cells engrafted in SCID mice. Science. 1992; 255:1137.
25. Larochelle A, Vormoor J, Lapidot T, et al. Engraftment of immune-deficient mice with primitive hematopoietic cells from β-thalassemia and sickle cell anemia patients: implications for evaluating human gene therapy protocols. Hum Mol Gen. 1995;4:163.
26. Nolta JA, Hanley MB, Kohn DB. Sustained human hematopoiesis in immunodeficient mice by cotransplantation of marrow stroma expressing human interleukin-3: analysis of gene-transduction of long-lived progenitors. Blood. 1994;83: 3041.
27. McCune JM, Namikawa R, Kaneshima H, Shultz LD, Lieberman M, Weissman IL. The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function. Science. 1988;241:1632.
28. Namikawa R, Weilbaecher KN, Kaneshima H, Yee EJ, McCune JM. Long-term hematopoiesis in the SCID-hu mouse. J Exp Med. 1990;172:1055.
29. Kyoizumi S, Baum CM, Kaneshima H, McCune JM, Yee EJ, Namikawa R. Implantation and maintenance of functional human bone marrow in SCID-hu mice. Blood. 1992;79:1704.
30. Shultz LD, Schweitzer PA, Christianson SW, et al. Multiple defects in innate and adaptive immunologic function in NOD/LtSz-Scid mice. J Immunol. 1995;154:180.
31. Larochalle A, Vormoor J, Hanenberg H, et al. Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: implications for gene therapy. Nature Med. 1996;2:1329.
32. Wermann K, Fruehauf S, Haas R, Zeller WJ. Human-mouse-xenografts in stem cell research. J Hematother. 1996;5:379.
33. Cashman JD, Lapidot T, Wang JCY, et al. Kinetic evidence of regeneration of multilineage hematopoiesis from primitive cells in normal human bone marrow transplanted into immunodeficient mice. Blood. 1997;89:4307.
34. Bhatia M, Wang JCY, Kapp U, et al. Purification of primitive human hematopoietic cells capable of repopulating immune-deficient mice. Proc Natl Acad Sci U S A. 1997;94:5320.
35. Wang JCY, Doedens M, Dick JE. Primitive human hematopoietic cells are enriched in cord blood compared with adult bone marrow or mobilized peripheral blood as measured by the quantitative in vivo SCID-repopulating cell assay. Blood. 1997;89:3919.
36. Gan OI, Murdoch B, Larochelle A, Dick JE. Differential maintenance of primitive human SCID-repopulating cells, clonogenic progenitors, and long-term culture-initiating cells after incubation on human bone marrow stromal cells. Blood. 1997;90:641.
37. Hao QL, Thiemann FT, Petersen D, Smogorzewska EM, Crooks GM. Extended long-term culture reveals a highly quiescent and primitive human hematopoietic progenitor population Blood. 1996;88:3306.
38. + cells in non-obese diabetic/severe combined immune-deficient mice. Blood. 1998;92:2641.
39. + and CD34+CD38-human hematopoietic progenitors assessed in immune-deficient mice. Blood. 1998; 91:1243.
40. Xu LC, Kluepfel-Stahl S, Blanco M, Schiffman R, Dunbar C, Carlsson S. Growth factors and stromal support generate very efficient retroviral transduction of peripheral blood CD34 cells from Gaucher patients. Blood. 1995;86:141.
41. Ward M, Piolo P, Ayello J, et al. Retroviral transfer and expression of the human multidrug resistance (MDR) gene in peripheral blood progenitor cells. Clin Cancer Res. 1996;2:873.
42. Bertolini F, Battaglia M, Corsini C, et al. Engineered stromal layers and continuous flow culture enhance multidrug resistance gene transfer in hematopoietic progenitors. Cancer Res. 1996;56: 2566.
43. Fruehauf S, Breems DA, Knaän-Shanzer, et al. Frequency analysis of multidrug resistance-1 gene transfer into human primitive hematopoietic progenitor cells using the cobblestone area-forming cell assay and detection of vector-mediated P-glycoprotein expression by rhodamine-123. Hum Gene Ther. 1996;7:1219.
44. Baum C, Hegewisch-Becker S, Eckert HG, Stocking C, Ostertag W. Novel retroviral vectors for efficient expression of the multidrug resistance (mdr-1) gene in early hematopoietic cells. J Virol. 1995;69:7541.
45. Eckert HG, Stockschläder M, Just U, et al. High-dose multidrug resistance in primary human hematopoietic progenitor cells transduced with optimized retroviral vectors. Blood. 1996;88:3407.
46. Nolta JA, Smogorzewska EM, Kohn DB. Analysis of optimal conditions for retroviral-mediated transduction of primitive human hematopoietic cells. Blood. 1995;86:101.
47. Wells S, Malik P, Ruscero M, Kohn DD, Nolta JA. The presence of autologous stromal cell layer increases glucocerebrosidase gene transduction of long-term culture-initiating cells (LTCIC's) from the bone marrow of a patient with Gaucher disease. Gene Ther. 1995;2:512.
48. Breems DA, Blokland EAW, Neben S, Ploemacher RE. Frequency analysis of human primitive hematopoietic stem cell subsets using a cobblestone area forming cell assay. Leukemia. 1994;8: 1095.
49. Hanenberg H, Xiao XL, Dilloo D, Hashinao K, Williams DA. Colocalization of retrovirus and target cells on specific fibronectin fragments increases genetic transduction of mammalian cells. Nature Med. 1996;2:876.
50. MoritzT, Dutt P, Xiao X, et al. Fibronectin improves transduction of reconstituting hematopoietic stem cells by retroviral vectors: evidence for direct viral binding to chymotryptic carboxy-terminal fragments. Blood. 1996;88:855.
51. Moritz T, Patel VP, Williams DA. Bone marrow extracellular matrix molecules improve gene transfer into human hematopoietic cells via retroviral vectors. J Clin Invest. 1994;93:1451.
52. Smith SL, Bender JG, Maples PB, et al. Expansion of neutrophil precursors and progenitors in suspension cultures of CD34+ cells enriched from human bone marrow. Exp Hematol. 1993; 21:870.
53. Schwarzenberger P, Spence S, Lohrey N, et al. Gene transfer of multidrug resistance into a factor-dependent human hematopoietic progenitor cell line: in vivo model for genetically transferred chemoprotection. Blood. 1996;87:2723.
54. Lichtenberg U, Quintrell N, Bishop JM. Human protein-tyrosine kinase gene HCK: expression and structural analysis of the promoter region. Oncogene 1992;7:849.
55. Van Beusechem VW, Kukler A, Heidt PJ, Valerio D. Long-term expression of human adenosine deaminase in rhesus monkeys transplanted with retrovirus-infected bone-marrow cells. Proc Natl Acad Sci U S A. 1992;89:7640.
56. Klimecki WT, Futscher BW, Grogan TM, Dalton WS. P-glycoprotein expression and function in circulating blood cells from normal donor volunteers. Blood. 1994;83:2451.
57. Chaudhary PM, Mechetner EB, Roninson IB. Expression and activity of the multidrug resistant P-glycoprotein in human peripheral blood lymphocytes. Blood. 1992;80:2735.
58. Cassel A, Cottler-Fox M, Doren S, Dunbar CE. Retroviral-mediated gene transfer into CD34-enriched human peripheral blood stem cells. Exp Hematol. 1993;21:585.
59. Lu M, Maruyama M, Zhang N, Levine F, Friedman T, Ho AD. High efficiency retroviral-mediated gene transduction into CD34+ cells purified from peripheral blood of breast cancer patients primed with chemotherapy and granulocyte-macrophage colony-stimulating factor. Hum Gene Ther. 1994; 5:203.
60. Elwood NJ, Zogos H, Willson T, Begley CG. Retroviral transduction of human progenitor cells. Use of granulocyte colony-stimulating factor plus stem cell factor to mobilize progenitor cells in vivo and stimulation by Flt3/Flk-2 ligand in vitro. Blood. 1996;88:4452.
61. Bunting KD, Galipeau J, Topham D, Benaim E, Sorrentino B. Transduction of murine bone marrow cells with an MDR1 vector enables ex vivo stem cell expansion, but these expanded grafts cause a myeloproliferative syndrome in transplanted mice. Blood. 1998;92:2269.
62. + peripheral blood progenitor cells. Biol Blood Marrow Transplant. 1997;3:236.
63. van der Loo JCM, Hanenberg H, Cooper RJ, Luo FY, Lazaridis EN, Williams DA. Nonobese diabetic/severe combined immunodeficiency (NOD/ SCID) mouse as a model system to study the engraftment and mobilization of human peripheral stem cells. Blood. 1998;92:2556.
64. Vormoor J, Lapidot T, Pflumio F, et al. Immature human cord blood progenitors engraft and proliferate to high levels in severe combined immunodeficient mice. Blood. 1994;83:2489.
65. +-enriched cells from umbilical cord blood in NOD/Ltz-scid/scid mice. Blood. 1997;90:85.
66. Bertolini F, Battaglia M, Lanza A, et al. Multilineage long-term engraftment potential of drug-resistant hematopoietic progenitors. Blood. 1997; 90:3027.
67. Goan SR, Fichtner I, Just U, et al. The severe combined immunodeficient-human peripheral blood stem cell (SCID-huPBSC) mouse: a xenotransplant model for huPBSC-initiated hematopoiesis. Blood. 1995;86:89.
68. Schilz AJ, Brouns G, Knoss H, et al. High efficiency gene transfer to human hematopoietic SCID-repopulating cells under serum-free conditions. Blood. 1998;92:3163.
69. Van Hennik PB, Verstegen MMA, Bierhuizen MF, et al. Highly efficient transduction of the green fluorescent protein in human umbilical cord blood stem cells capable of cobblestone formation in long-term cultures and multilineage engraftment of immunodeficient mice. Blood. 1998;92:4013.
70. Cheng L, Du C, Lavau C, et al. Sustained gene expression in retrovirally transduced, engrafting human stem cells and their lympho-myeloid progeny. Blood. 1998;92:83.
71. Fruehauf S, Wermann K, Buss EC, et al. Protection of hematopoietic stem cells from chemotherapy-induced toxicity by multidrug resistance 1 gene transfer. Recent Results Cancer Res. 1998; 144:93.
72. Conneally E, Cashman J, Petzer A, Eaves C. Expansion in vitro of transplantable human cord blood stem cells demonstrated using a quantitative assay of their lympho-myeloid repopulating activity in nonobese diabetic-SCID/SCID mice. Proc Natl Acad Sci U S A. 1997;94:9836.
73. Bhatia M, Bonnet D, Kapp U, Wang JCY, Murdoch B, Dick JE. Quantitative analysis reveals expansion of human hematopoietic repopulating cells after short-term ex vivo culture. J Exp Med. 1997;186:619.
74. Dao MA, Hannum CH, Kohn DB, Nolta JA. FLT3 ligand preserves the ability of human CD34+ progenitors to sustain long-term hematopoiesis in immune-deficient mice after ex vivo retroviral-mediated transduction. Blood. 1997;89:446.
75. Dao MA, Hashino K, Kato I, Nolta JA. Adhesion to fibronectin maintains regenerative capacity during ex vivo culture and transduction of human hematopoietic stem and progenitor cells. Blood. 1998;92:4612.
76. Lyman SD, Jacobsen SEW. C-kit ligand and flt3 ligand, stem/progenitor cell factors with overlapping yet distinct activities. Blood. 1998;91:1101.
77. Rebel VI, Tanaka M, Lee J-S. One-day ex vivo culture allows effective gene transfer into non-obese diabetic/severe combined immune-deficient repopulating cells using high-liter vesicular stomatitis virus G pseudotyped retrovirus. Blood. 1999;93:2217.
78. Tisdale JF, Hanazono Y, Seller SE, et al. Ex vivo expansion of genetically marked rhesus peripheral blood progenitor cells results in diminished long-term repopulating ability. Blood. 1998;92: 1131.
79. Kiem HP, Andrews RG, Morris J, et al. Improved gene transfer into baboon marrow repopulating cells using recombinant human fibronectin fragment CH-296 in combination with interleukin-6, stem cell factor, FLT-3 ligand, and megakaryocyte growth and development factor. Blood. 1998;92: 1878.
80. Conneally E, Eaves CJ, Humphries RK. Efficient retroviral-mediated gene transfer to human cord blood stem cells with in vivo repopulating potential. Blood. 1998;91:3487.
81. Luens KM, Travis MA1, Chen BP, Hill BL, Scollay R, Murray LJ. Thrombopoietin, kit ligand and flt2/ flt3 ligand together induce increased numbers of primitive hematopoietic progenitors from human CD34+ Thy-1+ Lin-cells with preserved ability to engraft SCID-hu bone. Blood. 1998;91:1206.
82. Naldini L, Blömer U, Gallay P, et al. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science. 1996;272: 263.
83. Reiser J, Harmison G, Kluepfel-Stahl S, Brady RO, Karlsson S, Schubert M. Transduction of nondividing cells using pseudotyped defective high-liter HIV type 1 particles. Proc Natl Acad Sci USA. 1996;93:15,266.
84. Miyoshi H, Smith KA, Mosier DE, Verma IM, Torbett, BE. Transduction of human CD34+ cells that mediate long-term engraftment of NOD/SCID mice by HIV vectors. Science. 1999; 283:682.
85. Sorrentino BP, McDonagh KT, Woods D, Orlic D. Expression of retroviral vectors containing the human multidrug resistance 1 cDNA in hematopoietic cells of transplanted mice. Blood. 1995;86:491.
86. Zaboikin MM, Schuening FG. Poor expression of MDR1 transgene in HeLa cells by bicistronic Moloney murine leukemia virus-based vector. Hum Gene Ther. 1998;9:2263.
87. Hildinger M, Fehse B, Hegewisch-Becker S, et al. Dominant selection of hematopoietic progenitor cells with retroviral MDR1 co-expression vectors. Hum Gene Ther. 1998;9:33.
88. Hawely RG, Lieu FHL, Fong AZC, Hawley TS. Versatile retroviral vectors for potential use in gene therapy. Gene Ther. 1994;1:136.
89. Hildinger M, Abel KL, Ostertag W, Baum C. Design of 5′ untranslated sequences in retroviral vectors developed for medical use. J Virol. 1999; 73:4083.
90. Jiang G, Mathias LA, Xu D, Pepper K, Malik P. Hepatitis virus posttranscriptional RNA export element (HPRE) can increase expression from tetroviral vectors and may improve the transport of intronless RNA of the normally intron-dependent β-globin cDNA [abstract]. Blood. 1998;92: 146a.